In IPF, myofibroblasts proliferating within fibroblastic lesions are CD90−, whereas normal lung fibroblasts are predominantly CD90+, and CD90+ and CD90− subsets have different functional properties (Sanders et al. 2007). The gene discussed is THY1; the disease is idiopathic pulmonary fibrosis.